Actively Recruiting

Phase 1
Age: 18Years - 50Years
All Genders
Healthy Volunteers
NCT06299410

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Led by Intra-Cellular Therapies, Inc. · Updated on 2025-01-28

30

Participants Needed

1

Research Sites

72 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study will be conducted as an open-label and single-center study to evaluate the occupancy of ITI-1284 to the dopamine D2 receptor, serotonin 2A (5-HT2A) receptor, and serotonin transporter (SERT) in healthy subjects.

CONDITIONS

Official Title

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy males and females aged 18 to 50 years (inclusive)
  • Body mass index (BMI) between 18 and 32 kg/m2 at screening
  • Minimum weight of 50 kg
  • Willing to remain in the hospital research unit during the inpatient period
Not Eligible

You will not qualify if you...

  • Clinically significant abnormality within 2 years before screening that may pose risk or affect study outcomes, including cardiac, liver, kidney, neurological, gastrointestinal, lung, endocrine, blood, immune diseases, or history of cancer
  • Abnormal vital signs at screening: supine systolic blood pressure > 140 mmHg or < 90 mmHg, diastolic blood pressure > 90 mmHg or < 50 mmHg, pulse rate > 100 bpm or < 45 bpm
  • History of psychiatric conditions that may impact study participation
  • Any condition preventing MRI or PET/CT scans (e.g., metal implants, claustrophobia, inability to fit in scanners)
  • Contraindications found from previous MRI or study MRI before baseline PET/CT scan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinical Site 1

New Haven, Connecticut, United States, 06520

Actively Recruiting

Loading map...

Research Team

I

ITI Clinical Trials

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects | DecenTrialz